DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Carbone F, Djamshidian A, Seppi K, Poewe W.
Apomorphine for Parkinson's disease: efficacy and safety of current and new formulations.
CNS Drugs 2019;
33 (09) 905-918
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.